HeartFlow Inc's stock surged 6.59% during intraday trading on Thursday, showcasing a significant upward movement for the healthcare company.
The price jump comes as analysts express mixed views on the stock. While Wells Fargo and JP Morgan both cut their price targets for HeartFlow Inc, Stifel Nicolaus maintained its Buy rating with a $40 price target, highlighting a divergence in analyst sentiment.
This conflicting guidance from major financial institutions appears to have fueled investor interest, with the market reacting positively to the continued bullish stance from Stifel despite the downward revisions from other firms.